Clinical Trial Update: Multi-modal Adverse Events Prediction for Premature Coronary Heart Disease Trial: MAP-CHD Trial

View source ↗

Summary

Clinical trial update for the MAP-CHD trial, which aims to predict adverse events in premature coronary heart disease using multi-modal data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Coronary Heart Disease

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Premature Coronary Heart Disease | Status: RECRUITING